Published in Neuromolecular Med on September 07, 2011
Higher brain BDNF gene expression is associated with slower cognitive decline in older adults. Neurology (2016) 1.49
7,8-dihydroxyflavone prevents synaptic loss and memory deficits in a mouse model of Alzheimer's disease. Neuropsychopharmacology (2013) 1.09
Serum brain-derived neurotrophic factor levels in different neurological diseases. Biomed Res Int (2013) 1.01
Neuroprotective effects of lithium: implications for the treatment of Alzheimer's disease and related neurodegenerative disorders. ACS Chem Neurosci (2014) 0.98
Molecular and neural bases underlying roles of BDNF in the control of body weight. Front Neurosci (2013) 0.98
Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders. Neuropsychiatr Dis Treat (2013) 0.95
Brain-derived neurotrophic factor levels in late-life depression and comorbid mild cognitive impairment: a longitudinal study. J Psychiatr Res (2013) 0.92
Brain amyloidosis ascertainment from cognitive, imaging, and peripheral blood protein measures. Neurology (2015) 0.88
Obesity as a risk factor for poor neurocognitive outcomes in older adults with heart failure. Heart Fail Rev (2014) 0.87
The demographic and medical correlates of plasma aβ40 and aβ42. Alzheimer Dis Assoc Disord (2013) 0.86
Beneficial effects of novel antagonists of GHRH in different models of Alzheimer's disease. Aging (Albany NY) (2012) 0.86
Amyloid-β oligomers induce tau-independent disruption of BDNF axonal transport via calcineurin activation in cultured hippocampal neurons. Mol Biol Cell (2013) 0.85
Sporadic Alzheimer disease fibroblasts display an oxidative stress phenotype. Free Radic Biol Med (2012) 0.83
The BDNF Val66Met polymorphism and plasma brain-derived neurotrophic factor levels in Han Chinese heroin-dependent patients. Sci Rep (2015) 0.81
Lack of an association of BDNF Val66Met polymorphism and plasma BDNF with hippocampal volume and memory. Cogn Affect Behav Neurosci (2015) 0.80
Synaptic therapy in Alzheimer's disease: a CREB-centric approach. Neurotherapeutics (2015) 0.79
Mood disorders in the elderly: prevalence, functional impact, and management challenges. Neuropsychiatr Dis Treat (2016) 0.79
Plasma BDNF levels are correlated with aggressiveness in patients with amnestic mild cognitive impairment or Alzheimer disease. J Neural Transm (Vienna) (2013) 0.79
Plasma BDNF levels associate with Pittsburgh compound B binding in the brain. Alzheimers Dement (Amst) (2015) 0.79
Surgical and Nonsurgical Interventions for Obesity in Service of Preserving Cognitive Function. Psychosom Med (2015) 0.78
Brain-derived neurotrophic factor protects against tau-related neurodegeneration of Alzheimer's disease. Transl Psychiatry (2016) 0.78
Comorbidity Factors and Brain Mechanisms Linking Chronic Stress and Systemic Illness. Neural Plast (2016) 0.77
Differential effects of glycogen synthase kinase 3 (GSK3) inhibition by lithium or selective inhibitors in the central nervous system. Naunyn Schmiedebergs Arch Pharmacol (2013) 0.77
The effect of soybean isoflavone on the dysregulation of NMDA receptor signaling pathway induced by β-amyloid peptides 1-42 in rats. Cell Mol Neurobiol (2015) 0.76
The negative effects of obesity and poor glycemic control on cognitive function: a proposed model for possible mechanisms. Curr Diab Rep (2014) 0.76
Serum Markers of Neurodegeneration in Maple Syrup Urine Disease. Mol Neurobiol (2016) 0.76
Combined assessment of DYRK1A, BDNF and homocysteine levels as diagnostic marker for Alzheimer's disease. Transl Psychiatry (2017) 0.75
Neuronal Gene Targets of NF-κB and Their Dysregulation in Alzheimer's Disease. Front Mol Neurosci (2016) 0.75
Brain-derived neurotrophic factor concentrations in tetraplegic athletes. Spinal Cord (2015) 0.75
Effects of brain-derived neurotrophic factor-pretreated neuron stem cell transplantation on Alzheimer's disease model mice. Int J Clin Exp Med (2015) 0.75
Pre-operative history of depression and cognitive changes in bariatric surgery patients. Psychol Health Med (2014) 0.75
Proteomic Analysis of Mitochondria-Enriched Fraction Isolated from the Frontal Cortex and Hippocampus of Apolipoprotein E Knockout Mice Treated with Alda-1, an Activator of Mitochondrial Aldehyde Dehydrogenase (ALDH2). Int J Mol Sci (2017) 0.75
Carbohydrate Supplementation Influences Serum Cytokines after Exercise under Hypoxic Conditions. Nutrients (2016) 0.75
The Pietà study: epidemiological investigation on successful brain aging in Caeté (MG), Brazil. Methods and baseline cohort characteristics. Arq Neuropsiquiatr (2011) 1.40
Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairment. World J Biol Psychiatry (2010) 1.12
Increased serum IL-1beta level in Alzheimer's disease and mild cognitive impairment. Dement Geriatr Cogn Disord (2009) 1.10
Peripheral biomarkers and illness activity in bipolar disorder. J Psychiatr Res (2010) 1.10
Increased serum levels of brain-derived neurotrophic factor in chronic institutionalized patients with schizophrenia. Neurosci Lett (2008) 0.99
Obsessive-compulsive disorder and immunology: a review. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.94
Serum brain-derived neurotrophic factor level is reduced in antidepressant-free patients with late-life depression. World J Biol Psychiatry (2010) 0.91
Increased serum levels of inflammatory markers in chronic institutionalized patients with schizophrenia. Neuroimmunomodulation (2008) 0.91
Increased soluble TNF receptor 2 in antidepressant-free patients with late-life depression. J Psychiatr Res (2010) 0.91
Blockade of CXCR1/2 chemokine receptors protects against brain damage in ischemic stroke in mice. Clinics (Sao Paulo) (2013) 0.88
Increased levels of adipokines in bipolar disorder. J Psychiatr Res (2011) 0.88
Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer's disease. J Alzheimers Dis (2010) 0.88
Chronic headache and comorbidities: a two-phase, population-based, cross-sectional study. Headache (2010) 0.86
Interleukin-1beta serum levels is increased in antidepressant-free elderly depressed patients. Am J Geriatr Psychiatry (2010) 0.85
The role of platelet-activating factor receptor (PAFR) in lung pathology during experimental malaria. Int J Parasitol (2012) 0.85
Loss of libido in Parkinson's disease. J Sex Med (2008) 0.84
Neurotrophic factors in obsessive-compulsive disorder. Psychiatry Res (2012) 0.84
Interleukin-6 and verbal memory in recurrent major depressive disorder. Neuro Endocrinol Lett (2011) 0.84
Suicidal ideation in Parkinson's disease. CNS Spectr (2009) 0.83
Cerebrospinal fluid levels of chemokines in HIV infected patients with and without opportunistic infection of the central nervous system. J Neurol Sci (2009) 0.83
Psychiatric disorders in myasthenia gravis. Arq Neuropsiquiatr (2011) 0.83
Imipramine reverses depressive-like parameters in pneumococcal meningitis survivor rats. J Neural Transm (Vienna) (2011) 0.81
A cytokine study of adult patients with obsessive-compulsive disorder. Compr Psychiatry (2012) 0.81
A kinetic study of the cytokine/chemokines levels and disruption of blood-brain barrier in infant rats after pneumococcal meningitis. J Neuroimmunol (2010) 0.81
Generalized anxiety disorder and the Hamilton Anxiety Rating Scale in Parkinson's disease. Arq Neuropsiquiatr (2010) 0.81
Pathophysiology of neonatal acute bacterial meningitis. J Med Microbiol (2013) 0.81
Mechanical hypernociception in experimental autoimmune encephalomyelitis. Arq Neuropsiquiatr (2009) 0.80
Depressive symptoms and perception of quality of life in Parkinson's disease. Arq Neuropsiquiatr (2009) 0.80
Association between inflammatory biomarkers in plasma, radiological severity, and duration of exposure in patients with silicosis. J Occup Environ Med (2014) 0.80
Soluble inflammatory markers as predictors of hepatocellular damage and therapeutic response in chronic hepatitis C. Braz J Infect Dis (2009) 0.79
Brain-derived neurotrophic factor plasma levels are associated with mortality in critically ill patients even in the absence of brain injury. Crit Care (2012) 0.79
Animal models of neurodegenerative diseases. Rev Bras Psiquiatr (2013) 0.79
Immunosenescence is associated with human cytomegalovirus and shortened telomeres in type I bipolar disorder. Bipolar Disord (2013) 0.79
Absence of CCR5 increases neutrophil recruitment in severe herpetic encephalitis. BMC Neurosci (2013) 0.79
Lithium and topiramate association in the treatment of comorbid pathological gambling and bipolar disorder. Aust N Z J Psychiatry (2007) 0.78
Bipolar disorder and multiple sclerosis. Arq Neuropsiquiatr (2007) 0.78
Neuropsychiatry of Parkinson's disease. Arq Neuropsiquiatr (2009) 0.78
Inhibition of indoleamine 2,3-dioxygenase prevented cognitive impairment in adult Wistar rats subjected to pneumococcal meningitis. Transl Res (2013) 0.78
Oxidative stress, cytokine/chemokine and disruption of blood-brain barrier in neonate rats after meningitis by Streptococcus agalactiae. Neurochem Res (2011) 0.78
Limbic encephalitis manifesting as a psychotic disorder. Rev Bras Psiquiatr (2006) 0.78
Interleukin-1β Receptor Antagonism Prevents Cognitive Impairment Following Experimental Bacterial Meningitis. Curr Neurovasc Res (2015) 0.78
The 5-lipoxygenase (5-LOX) Inhibitor Zileuton Reduces Inflammation and Infarct Size with Improvement in Neurological Outcome Following Cerebral Ischemia. Curr Neurovasc Res (2015) 0.78
Klebsiella pneumoniae meningitis induces memory impairment and increases pro-inflammatory host response in the central nervous system of Wistar rats. J Med Microbiol (2013) 0.77
TNF-α, IL6, and IL10 polymorphisms and the effect of physical exercise on inflammatory parameters and physical performance in elderly women. Age (Dordr) (2013) 0.77
Soluble inflammatory markers as predictors of virological response in patients with chronic hepatitis C virus infection treated with interferon-α plus ribavirin. Mem Inst Oswaldo Cruz (2011) 0.77
Brain-derived neurotrophic factor in patients with chronic hepatitis C: beyond neurotrophic support. Biol Psychiatry (2012) 0.77
Protection of blood brain barrier integrity and modulation of inflammatory mediators during treatment of pneumococcal meningitis with daptomycin or ceftriaxone. Curr Neurovasc Res (2014) 0.77
Depressive disorders in Parkinson's disease may be due to a shared immune-mediated neurodegenerative process. Med Hypotheses (2007) 0.77
Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer's Disease. Neuromolecular Med (2015) 0.77
Corticosteroids in the treatment of acute Sydenham's chorea. Pediatr Neurol (2006) 0.76
Borderline personality features possibly related to cingulate and orbitofrontal cortices dysfunction due to schizencephaly. Clin Neurol Neurosurg (2008) 0.76
Dopamine dysregulation syndrome in Parkinson's disease: case report. Arq Neuropsiquiatr (2006) 0.76
Up-regulation of chemokines and their receptors may contribute to pain in multiple sclerosis. Med Hypotheses (2008) 0.75
Psychiatric syndromes secondary to central nervous system infection. Rev Bras Psiquiatr (2012) 0.75
Migraine with persistent visual aura: response to furosemide. Clinics (Sao Paulo) (2009) 0.75
Brazilian version of the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E). Epilepsy Behav (2010) 0.75
Major depression in Parkinson's disease. Rev Bras Psiquiatr (2009) 0.75
Insights into inflammation and epilepsy from the basic and clinical sciences. J Clin Neurosci (2012) 0.75
Stuporous catatonia in an elderly bipolar patient: response to olanzapine. Aust N Z J Psychiatry (2006) 0.75
Use of clozapine in Brazilian patients with Parkinson's disease. Arq Neuropsiquiatr (2008) 0.75
Systemic toxicity in early-stage mood disorders. J Psychiatr Res (2011) 0.75
Trichotillomania in acute Sydenham's chorea. Aust N Z J Psychiatry (2007) 0.75